Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GINE-CANESTEN 20 mg/g CREMA VAGINAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/GINE-CANESTEN 20 mg/g CREMA VAGINAL

Approved

STANDARD

GINE-CANESTEN 20 mg/g CREMA VAGINAL

Bayer Hellas A.E.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 9, 2021
Approval ID: 9364ceea53cd2fdb
Company: Bayer Hellas A.E.
Type: Standard

Approval Details

Approval Id: 9364ceea53cd2fdb
Drug Cima Aemps Name: GINE-CANESTEN 20 mg/g CREMA VAGINAL
Register Number: 11003-29-03-1999IP
Holder Company Name: Bayer Hellas A.E.
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2021-12-09
Dosage Form: CREMA VAGINAL
Dose: 2 % clotrimazol/ 100 g
Route Of Administration: VÍA VAGINAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Bayer Hellas A.E.

Active Ingredients

CLOTRIMAZOL

2,00 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 9, 2021

Approval ID

9364ceea53cd2fdb

Type

Standard

Back to CIMA-AEMPS Approvals